Certified by Founder Lodge
ShangBay Capital
United States - Palo Alto, California
INVESTOR
1 Disclosed Funding Rounds $22,000,000
11 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ShangBay Capital is a venture capital company that brings both U.S. and global investors access to best-in-class investments in the U.S. medical devices, biotechnology, and digital health sec
| Company | Date | Round | Raised |
|---|---|---|---|
 Telesair, Inc |
January, 12 ,2023 | Series A | $22,000,000 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 Noah Medical |
April, 20 ,2023 | Series B | $150,000,000 |
 Solenic Medical |
June, 21 ,2023 | Series A | $5,100,000 |
 Presidio Medical, Inc. |
June, 27 ,2023 | Series C | $72,000,000 |
 Luminopia |
June, 29 ,2023 | Series A | $16,000,000 |
 Laplace Interventional |
July, 25 ,2023 | Series B | $12,900,000 |
 Avation Medical |
February, 02 ,2024 | Unknown | $22,000,000 |
 Venova Medical, Inc. |
September, 05 ,2024 | Series B | $30,000,000 |
 Inquis Medical, Inc. |
November, 05 ,2024 | Series B | $40,000,000 |
 Fluid Biomed Inc. |
December, 18 ,2024 | Series A | $27,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
